Saudi Arabia's national digital health leader and the venture creation firm behind Moderna have signed a strategic agreement to apply artificial intelligence to the Kingdom's health data. The deal, signed June 23 at the BIO International Convention in San Diego, pairs Lean Business Services Company's national health platforms with Flagship Pioneering's portfolio of more than 100 life sciences ventures.
The Memorandum of Understanding sets up a framework for the two organizations to evaluate research programs, build governance models, and strengthen Saudi Arabia's biomedical ecosystem. Any resulting projects will need to clear privacy safeguards, regulatory requirements, and agreed governance frameworks under Saudi law.
What each side brings to the table
Lean Business Services, a Public Investment Fund company, operates the Kingdom's digital health transformation programs. It controls interoperability infrastructure, advanced analytics capabilities, and AI-powered solutions that connect healthcare stakeholders across Saudi Arabia. Flagship Pioneering has originated and fostered more than 100 scientific ventures since 2000, including Moderna, Generate Biomedicines, and Valo Health. The firm manages $14 billion in assets.
"We are in a new era in which AI and health data are fundamentally reshaping how we understand disease, discover medicines, and improve patient outcomes," said Junaid Bajwa, M.D., Senior Partner at Flagship Pioneering. "Flagship has been at the forefront of applying AI across scientific research, platform innovation, and company creation, and we believe the combination of Lean's exceptional data infrastructure and Saudi Arabia's ambitious vision creates a uniquely powerful opportunity."
Vision 2030 and the push into life sciences
The collaboration directly supports Saudi Arabia's Vision 2030 goals to grow research and development capabilities, attract global expertise, and build a competitive life sciences sector. Eng. Mohanned Alrasheed, CEO of Lean Business Services, framed the deal around the Kingdom's existing investments. "Saudi Arabia is uniquely positioned to lead this transformation through its investments in digital health, AI, and healthcare innovation," he said. "Together with Flagship Pioneering, we aim to strengthen Saudi Arabia's life sciences ecosystem and support the Kingdom's ambition to become a global leader in health innovation under Vision 2030."
In the first twelve months, the partners will focus on evaluating priority initiatives, establishing foundational governance models, and identifying opportunities to expand the Kingdom's life sciences capabilities. The work spans scientific research, healthcare innovation, and AI for Science & Research applications - areas where Flagship's venture creation model has already produced companies working on precision medicine and generative biology.
Why this matters for healthcare professionals
For healthcare leaders and clinicians, this agreement signals that Saudi Arabia is building the infrastructure to make national-scale health data useful for drug discovery and treatment personalization. When a large, centralized health system connects its data to firms that know how to turn that data into medicines and diagnostics, the result can accelerate how quickly new therapies reach patients. Professionals working in or with the Kingdom's health system should watch for the governance frameworks and pilot programs that emerge from this collaboration - they will shape how AI for Healthcare gets deployed in clinical settings across the region.
Your membership also unlocks:
